Placebo controlled trial of LentinexHP in colorectal cancer approaches halfway stage Independent audit confirms no serious or other adverse events GlycaNova AS, the Norwegian biotechnology company focused on structurally intact beta-glucans for human and animal...
First patient dosed in clinical trial of LentinexHP in late-stage colorectal cancer Pioneering placebo-controlled trial of a novel beta-glucan dietary supplement administered alongside chemotherapy GlycaNova AS, the Norwegian biotechnology company focused on... 
